CommunicationStrategy & Plan 2018 WP7 | 25 January 2018

“PATIENTS affected by Hematologic

Malignancies still have unmet needs.We will address their urgent unmet

needs, such as faster diagnosis and personalized therapies.

By using Big Data SHARING among all relevant stakeholders involved,

HARMONY aims to improve patient outcomes.

”

PAGE 2

Lead contributors WP7 Ellen de Waal, EHA

Carin Smand, EHA

Other contributors WP7 Aliki Taylor (TAKEDA)

Louise Huneault (NOVARTIS)

Due date M01

Delivery date 25 January

Deliverable type PDF

Dissemination level Internal

Description of Action Version Date

8 25 January 2018

LOG

PAGE 3

1. Introduction 6

2. Communication Objectives for 2018 7

3. Communication Strategy for 2018 8

4. Outlining Communication Plan for 2018 9

5. Communication Processes and Organization 11

6. In addition 12

Core team of WP7 14

Objectives specific communication activities 15

Objectives general communication activities 20

Overall Communication Strategy & Plan [compressed] 22 2017: A solid foundation

Harmony Alliance Partners 2017 28

Content

Annexes

PAGE 4

“We believe that better therapy

access and improved care for patients with various

Hematologic Malignancies (HMs) can be provided by empowering clinicians,

patients and policy stakeholders.

”

PAGE 5

In 2017 the HARMONY Alliance (HARMONY) has established a sound foundation for the development and execution of communication and dissemination activities. In 2018 HARMONY will continue to translate valuable information into clear content, to be shared widely throughout the various HARMONY multi-layered communication channels.

We can only make a difference by communicating about real and effective developments and achievements which are realized by the teams of the HARMONY Work Packages and Bench-to-Bedside Projects. Not by plans and intentions.

We can only make a difference in finding the right people to connect and finding the right information to catch their interest.

WP7 will continue to play a pivotal role in the communication and dissemination activities of the HARMONY Alliance, both internal as well as external. WP7 will work even more closely with WP1, WP Leaders, KOLs and the PMO.

UniqueTranslating a plan in a funding agreement and ultimately into a vibrant virtual organization with people, projects and results requires specific expertise and active involvement from all WPs in communication activities.

This calls for professionals with extensive experience in the sector and with the appropriate networks and personal contacts.

Requirements Communicating for and about the HARMONY Alliance requires:

− A serious and balanced approach in communicating about topics, projects, people, organizations (balance public/private – balance Big Data and disease topics - etc.);

− A personal approach; − Making choices; − Thinking broadly (instead of in operational

details); − Thinking out-of-the-box (cross stakeholder;

cross sector; combine and try to find matches); − Quality and consistency in content and style; − Safeguarding identity and reputation; − Togetherness in the Alliance community; − Active promotion of HARMONY in one’s own

organization; − Active promotion of HARMONY in one’s own

networks; − A steady growth of the community.

1. Introduction1.

PAGE 6

Internal − Raise more awareness among the contacts of

the different WPs about the progress that is being made and achievements that have been realized;

− Raise awareness among all contacts that data is really needed: o Only with data HARMONY will have

substance;o As a partner make that step and share

data;o Stimulate others within the community to

share data. − Stimulate WP leads and contacts to contribute

to our Communication Objectives by sharing realistic and high value content;

− Stimulate interaction between WPs to improve understanding about:o Internal matters such as: People in the

teams; The progress that is being made in each WP;

o External matters such as: Key messages which are communicated; Relevant additional information which is available for further use.

− Keep WP contacts engaged and ensure they feel like a valued member of the Alliance i.e. the HARMONY Community.

External − Expand the outreach to hematology

professionals and a broader audience; − Make HARMONY more ‘personal’ and

‘accessible’ by finding additional HARMONY ambassadors within the HARMONY Community to ‘spread the word’;

− Find more and innovative ways to reach specific target audiences, such as:o Patient organizations;o Regulators;o European policy makers.

2. Communication Objectives for 20182.

PAGE 7

Looking back − 2017: HARMONY year 1:

Awareness & IntroductionCommunications activities have contributed significantly to the overall success of HARMONY in the past year. We defined the HARMONY identity and brand and created a sound foundation for internal and external communications and dissemination. HARMONY was introduced and represented at various European and international conferences.

Looking ahead − 2018: HARMONY year 2: Clarifying &

Connecting − 2019: HARMONY year 3: Growth & Benefits − 2020: HARMONY year 4: Education & Strength − 2021: HARMONY year 5: Results & Embedding

FocusThe Communication Strategy for 2018, HARMONY year 2, is based on taking the next step:

− From raising awareness, we need to really connect;

− From clarifying who we are and what we do, we really need to find out how we can benefit from stakeholders and how stakeholders can benefit;

− From offering ways to engage, we need to build stronger relationships;

− From being just a contact in our Community and Network, we need to intensify the relationship and strive for actual commitment (data custodians);

3. Communication Strategy for 20183.

PAGE 8

This document is shaped as an Executive Summary. From strategy to plan:

4.1 Develop and execute specific communication activities to connect with new and carefully selected key individuals:

− Masterclasses for patient organizations In collaboration with: WP2 and WP6 Target Audience: Representatives from

European patient organizations representing specific HMs/disease groups

− Organizing Webinars In collaboration with: WP1, WP2 and WP6 Target Audience: Representatives from

European national hematology societies

− Organizing Roundtable meetings for policy makers

Target Audience: Representatives from European Policy organizations

− Organizing a hackathon Target Audience: Young hematologists,

Bioinformaticians, SME’s

− Organizing Multiple activities during the 23rd Congress of EHA in Stockholm, from 14-17 June 2018

In collaboration with: KOLs, WP Leaders Target Audience: Hematologists, Clinicians,

Multi stakeholders

− Giving presentations at selected European Conferences

In collaboration with: WP Leaders and WP teams

Target Audience: Hematologists, Clinicians, Multi stakeholders

− Sending targeted personalized emails

− Developing a range of ‘what Harmony means to me’ articles with very short videos

− Developing very short and simple animation(s)

− Approaching selected specialized media

4. Outlining the Communication Plan for 2018

Talks

4.

PAGE 9

4.2 Continue to develop and execute the general communication activities to maintain the flow of information and grow our network such as:

Internal − Introduce the HARMONY Community Platform; − Stimulate the ‘use’ to work with the

Community Platform; − Make optimum use of the features of the

Community Platform; − Develop and distribute newsletters which not

only communicate about achievements and results, but will also put people and teams in the spotlight;

− Connect with new HARMONY Partners and Associated Members and make them feel welcome;

− Connect with communication professionals of HARMONY Partners and Associated Members and work together.

External − Expand the HARMONY website and related

social media activities; − Develop and distribute newsletters; − Develop and distribute new communications

materials such as explanatory video animations;

− Develop thematic articles consisting of text, images and video based on the specific needs of the stakeholders;

− Develop and distribute press releases; − Expand the communication kit for external

meetings, consisting of PowerPoint presentations, banners, brochures, flyers etc.;

− Make more use of communication channels of HARMONY Partners and Associated Members;

− Make more use of communications channels of the EU, IMI, EFPIA and ‘sister’ IMI Projects;

− Participate in large European and international conferences by means of presentations, booths, hand-out inserts, presenting scientific publications, abstracts and posters.

Communication HubThe WP7 team will offer strategic, creative and practical help to Partners and Associated Members in communicating about HARMONY and its work. Examples are:

− Customized PPT presentations; − Providing content for communication

channels of Partners and Associated Members; − Providing input and arrange for additional

promotion in case of meetings organized by Partners and Associated Members;

− Developing special online workspaces in the Community Platform (for instance for the Policy Health Stakeholder Feedback Forum (PHSFF).

BD4BO/DO-IT − The WP7 team will offer strategic, creative

and practical support to IMI’s Big Data for Better Outcomes (BD4BO) program and its Coordination/Support Action – DO-IT;

− In addition, the WP7 team will align with the other BD4BO disease projects ROADMAP, BigData@Heart and future projects. Members of WP7 will participate in online and F2F meetings, will provide input and feedback on materials developed by BD4BO/DO-IT and will provide updates about the developments and results of HARMONY.

PAGE 10

The communication, dissemination and training activities are managed by the European Hematology Association (EHA). The organization of HARMONY Communication and Dissemination activities are based on the tasks and structure of WP7.

WP7 consists of 2 Leaders, a co-Leader, an Executive Team, a Dissemination and Communication Board (DCB) and a Communication Manager. See Annex 2. To ensure good management, and maximum involvement and approval of content by the WP7 Work Team, collaboration will take place by means of:

− Monthly teleconference meetings; − Ad hoc teleconference meetings in case of

urgent communication matters; − Making use of the HARMONY Communication

Platform (WP7 workspace, Message Board and targeted emails) and website;

− Personal phone calls as required; − Proposals and memo documents about

specific communication topics; − WP7 monthly update document, including

reports and action lists.

To ensure good engagement, involvement and approval of content by other WPs, the working relationship with the WP Leaders and KOLs will be intensified. Collaboration will place by means of:

− Making use of the HARMONY Communication Platform (WP workspaces, Message Board and targeted emails);

− Personal phone, Skype or Zoom calls; − Meetings at the General Assembly; − Meetings at other events in which members

of the WP7 team are participating.

5. Communication Processes and Organization

5.

PAGE 11

In order to manage all communication and dissemination activities, as well as informing the WP7 team and connected HARMONY community members, WP7 is working with the following management files:

− A ‘work in progress’ document; − An overall planning; − A content planner; − A stakeholder matrix; − A calendar of events.

6. In addition6.

“We trust that, by making use of today’s Big Data technologies,

we can accelerate more efficient drug development,

regulatory evaluation, access appraisal and treatment

strategies.

”

PAGE 12

Core team of WP7 14

Objectives specific communication activities 15

Objectives general communication activities 20

Overall Communication Strategy & Plan [compressed] 22 2017: A solid foundation

Harmony Alliance Partners 2017 28

Annexes

WP7 leadCarin Smand, Executive Director, European Hematology Association (EHA);Tbd, Novartis.

WP7 communication teamEllen de Waal, Communication Manager,European Hematology Association (EHA);Louise Hunault, Head of Patient Relations,Hematology, Oncology Region Europe,Novartis;Aliki Taylor, Director Global OutcomesResearch Takeda.

Liaison WP1 for WP7Project Management Office: Elena del Rey, SYNAPSE

The WP7 Dissemination and Communication Board (DCB) consists of

Maole José Cerezo Ceballos – representing WP3Jan Geissler, Leukanet – representing WP6 Santiago Moralejo del Arco, Institute of Biomedical Research of Salamanca – representing WP1Aliki Taylor, Takeda – representing WP2Klaus Wasserman, Medical Universitat Wien (MUW) – representing WP8The DCB is led by Carin Smand, European Hematology Association.

Core team of WP7

Annex 1

PAGE 14

1. Masterclasses for patient organizations

IN COLLABORATION WITH: WP2 AND WP6

Objectives: − Connect patient organizations with

HARMONY; − Connect patient organizations with specific

HARMONY Disease Groups; − Learn what patient organizations need with

regard to information; − Build a relationship and stay in touch.

Target Audience: Representatives from European patient organizations representing specific HMs/disease groups:

− European Cancer Patient Coalition, EWM Network, The ITP Support Organisation, Lymphoma Coalition Europe, Myeloma Patients Europe (MPE), Leukemia CARE, CML Advocates;

− More to find in collaboration with HARMONY Community;

− Maximum number of participants approximately 25.

Theme: Big Data in Health − What does this mean for HM patients in

specific?; − When can HM patients expect results?; − How can HM patients be involved?

Timing/Venue: Spring & Autumn/EHA, The Hague.

Setup/Programme: − Evening of arrival: Informal welcome dinner; − Next Day: Morning session with

one HARMONY Ambassador incl. Q&A, lunch, afternoon session with one HARMONY Ambassador including Q&A, informal wrap-up, ending at 17:00 hrs.;

− In addition: select 7 participating patient organizations for video interviews during the day.

Expected results: − HARMONY Q&A for patient organizations; − Inventory what patient organizations

want/need with regard to information/ communications;

− Contacts for external newsletter.

Objectives specific communication activities

Annex 2

PAGE 15

2. Webinars

IN COLLABORATION WITH WORK PACKAGES, 2, 3, 4, 5, 6 AND 8.

Objectives: − Connect with specific stakeholders who are

important for one or more WPs; − Learn what these stakeholders need with

regard to information and communication from HARMONY;

− Build a relationship and stay in touch.

Target Audience: − In close collaboration with the WPs,

stakeholders are selected carefully; − Carefully selected stakeholders; − Unlimited number of participants.

Theme: Big Data in Health − What is Big Data?; − What does this mean for hematologists

and clinicians? Or what does it mean for other specific stakeholders which are identified?;

− What is valuable data and how about sharing data?

Timing: 2 sessions in spring & sessions in autumn.

Setup/Programme: − 1 session is 90 minutes and exists of 1

HARMONY Ambassador incl. Q&A

Expected results: − HARMONY Q&A for national organizations; − Inventory what national organizations

want/need with regard to information/ communications;

− Contacts for external newsletter.

3. Round table meetings for policy makers

Objectives: − Presenting the largest public private

partnership in hematology; − Presenting tangible examples; − Discussion on changes to be expected and

which hurdles need to be taken; − Build a relationship and stay in touch.

Target Audience: Representatives from European Policy organizations:

− Carefully selected; − Maximum amount of participants

approximately 25.

Theme: HARMONY Update: Big Data in Health: Where will HARMONY make the difference in HMs.

Dates/Venue: Autumn (check out possibilities at the 10th IMI anniversary symposium.

Setup/Program Roundtable: − Half a day or 2-hour session; − 2 Keynote presentations + discussion with

professional moderator.

Expected results: − More visibility of HARMONY in policy circles; − Feedback and input by participants; − Contacts for external newsletter; − See also point 3.6.

PAGE 16

4. The HARMONY hackathon

Objectives: − Connect young talent; − Connect small companies and startups; − Connect groups of people who normally do

not work together in hematology; − Profile HARMONY within subgroups of our

stakeholders; − Build a relationship and stay in touch; − Attract a different kind of publicity.

Target Audience: Young hematologists, Bioinformaticians, SME’s

Note: to be discussed, maybe plan for 2019

5. Multiple activities during the 23rd Congress of EHA in Stockholm, from 14-17 June 2018

IN COLLABORATION WITH: KOLS, WP LEADERS

Target Audience: Hematologists, Clinicians, Multi stakeholders.

Activities: To be discussed within WP7 and with program committee EHA23:

− Round table meeting for KOLs and carefully selected hematologists and clinicians;

− Interactive session at the advocacy track of the Congress;

− Interactive sessions or participating as a speaker at other small and medium-sized European and international conferences;

− Dinner with lecture for national societies; − An exhibition corner in the booth of EHA; − Video interviews.

PAGE 17

6. Participation in (provisional) selected European and international Conferences in 2018

IN COLLABORATION WITH: WP LEADERS, KOLS, WP TEAMS AND B-T-B PROJECT TEAMS (PROVISIONARY SELECTION)

Target Audience: Hematologists, Clinicians, Multi stakeholders

Conference Date Location

R&D Data Intelligence Leaders Forum 23-24 January Basel

BD4BO Group Event 29-30 January Stockholm

EHA EC Board Meeting 31 January The Hague

EHA KOL Meeting 5-6 February The Hague

EHA-SWG Scientific Meeting on Integrated Diagnosis Strategies in Oncohematology for the Management of Cytopenias and Leukocytosis

8-10 February Barcelona

Deutsche Krebskongress 18 February Berlin

Cancer Evolution – Genetic and Epigenetic Evolution of HN Symposium

18 March Munich

ELN Meeting 20-22 March Venice

EAPM: Personalized Med. and the Big Data Challenge 27-28 March Brussels

EHA-SWG Scientific Meeting on New Molecular Insights and Innovative Management Approaches for Acute Lymphoblastic Leukemia

12-14 April Barcelona

AACR Annual Meeting 2018 14-18 April Chicago, USA

X International Meeting on Hematology Focus on Guidelines and Recommendations

18 April Florence

Bio-IT World Conference & Expo 2018 15-17 May Boston, USA

29th Annual Meeting of the International BFM Study Group 19-20 May Helsinki

11th Biennial Childhood Leukemia and Lymphoma Symposium

21-22 May Helsinki

EHA23 14-17 June Stockholm

3rd General Assembly 2018 4-5 October Valencia

ASHG 2018 16-20 October San Diego, USA

SEHH Congress 11-13 October Granada

IMI 10th anniversary scientific symposium 22-23 October Brussels

EAPM 2nd Annual Congress 26-28 November Milan

BioData World Conference 28-29 November Basel

ASH Congress 2018 1-4 December San Diego, USA

PAGE 18

7. Targeted personalized emails

In collaboration with: WP1 (The SOP needs to be translated into a more user-friendly document)

Target Audience: − Prospective Partners and Associated

Members and follow up; − Partners and Associated Members to

submit bench-to-bedside proposals; − Other relevant European and International

Alliances on Big Data and a disease area (beyond BD4BO).

8. ‘What Harmony means to me’ articles with very short videos

− To demonstrate increasing and meaningful connections in and outside the Alliance;

− To use in activities as proposed above.

9. Very short and simple animation(s)

− To explain difficult topics; − To use in all communication activities.

10. Specialized media

− Approach and check willingness to publish our articles;

− To develop personal relations for future news;

− HemaSphere is already approached and will post HARMONY articles on a regular base;

− Involve communication professionals of the Partners;

− Articles will be of both popular and scientific nature.

Talks

PAGE 19

1. Objectives HARMONY Website

− To communicate information about the goals, objectives, mission, vision, projects, activities, news, and results of the European Network of Excellence, HARMONY’s 8 Work Packages, and its 51 partners;

− To function as a portal for dissemination activities;

− To connect, inspire, inform, and engage at every level and across the spectrum of experts, groups, and professionals involved;

Target Audience/UsersThe website will reach out not only to professionals, but to lay people as well, and will include:

− All contacts that are part of HARMONY Alliance’s Partners, Associated Members, funders (EFPA, IMI) and BD4BO/DO-IT projects;

− Key stakeholders in the clinical, academic, patient advocacy, health technology assessment, regulatory, economical, ethical, and pharmaceutical fields; and

− Citizens interested in health issues.

In addition − The HARMONY website is designed to grow

according to the needs of its users and of the HARMONY Alliance;

− Twice a year the website will be evaluated and upgraded and expanded accordingly.

2. Objectives HARMONY Community Platform

− To offer an interactive, online, secure platform to connect Partners and Associate Members;

− To provide an engaging online environment to co-create projects and activities, as well as to nurture collaboration within the overall Alliance, the 8 Work Packages and future Bench-to-Bedside Projects;

− To optimize the flow & exchange of knowledge within the Partner network.

What is the Community Platform? − More than just a repository -> a dedicated

place to work together with a vault/repository where confidential and non-confidential documents and images are gathered;

− An information management tool for internal communications;

− A source of content for external communications.

− Most of the collaboration will take place within (closed, private) Work Packages or future B-to-B projects, which have designated members.;

− For these teams there will be dedicated workspaces, which include a clear Work Package / project description, feed of recent activities by the members (with commenting options), list of members, calendar options with tasks, notifications and a list of files;

Objectives general communication activities

Annex 3

PAGE 20

− Engagement for the community is key and therefore the platform includes a notification system, email alerts, newsletter possibility, extensive discussion threads attached to each piece of information and an internal messaging functionality to exchange messages from one member to another.

Target Audience/Users − Connecting the 50+ HARMONY Partners

and (official) Associated Members (up to 200 contacts).

In addition − The HARMONY website is designed to grow

according to the needs of its users and of the HARMONY Alliance;

− Annually the community platform will be evaluation and accordingly upgraded and expanded.

3. Objectives Newsletters

Newsletters are part of our internal and external communications toolkit and have an informative and supporting function. The content of the newsletter should add value to our readers and will not contain any confidential information.

HARMONY Alliance Newsletter | For Internal Communications

Objectives − To function as an internal communication

tool to inspire, inform, connect, engage, align, and nurture collaboration between people and the organizations they represent;

− To transfer knowledge and valuable information in an efficient and consistent manner;

− To stimulate visits to/use of the HARMONY external website and of the HARMONY internal Community Platform;

− To motivate readers to share their insights and information related to HARMONY; and

− To make readers enthusiastic about sharing relevant items within their communication channels.

Target Audience − All contacts which are part of HARMONY

Alliance’s partners, Associated Members, funders (EFPA, IMI), and BD4BO/DO-IT projects.

HARMONY Alliance News & Views | For External Communications

Objectives − To reach out to a broader audience with

information introducing the Alliance, the progress and results of the bench-to-bedside projects, and facts on related outcomes; and

− To communicate the general message, which is to encourage interest in hematology research and the contribution of Big Data analyses. The key message: Join the HARMONY Alliance!

Target audience:Key individuals working at Patient and Societal organizations, Hospitals and Clinics, Medicine authorities and regulatory institutions, Health technology assessment organizations, Payers/Policy/Funding Organizations, Pharmaceutical companies and industry associations, Information and communications technology companies, other relevant European and international alliances and in the media.

NewsflashesAre short. 1 or 2 topic newsletters to gain extra attention to and promote specific activities.

PAGE 21

Overall Communication Strategy & Plan [compressed]

2017: A solid foundation

Deliverable Number: HARMONY/D7.02Delivery Date: 20 April 2017 | Updated in July, October and November 2017.Authors: Carin Smand, Ellen de Waal

Annex 4

PAGE 22

1. INTRODUCTION

The Harmony Alliance, as a multi-level organizational structure, brings together representatives from different stakeholders and parallel activities across 8 Work Packages. Keys to successfully meet the communication and dissemination goals and objectives of the Harmony Alliance are:

− Solid and effective communication activities; − Clear and manageable processes for content

development and production; − Efficient, enthusiastic and well-organized core

communication team; − An engaged internal and external community.

This Communication Plan will further explain the steps to be taken in accordance with Annex 1 of the Grant Agreement - Description of Action (DoA).

1.1 Who we are − HARMONY is the acronym for the Healthcare

Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY;

− The HARMONY Alliance is a European Network of Excellence in hematology, consisting of 51 partners;

− Our partners, from 11 European countries, are key stakeholders in the clinical, academic, patient’s advocacy, Health Technology Assessment, regulatory, economic, ethical, information and communications technology and pharmaceutical fields;

− The HARMONY Alliance is funded through the Innovative Medicines Initiative (IMI); Europe’s largest public-private initiative aiming to speed up the development of better and safer medicines for patients.

− See figure 1.

1.2 Our ObjectivesThe HARMONY Alliance:

− Aims to meet unmet major needs in Hematologic Malignancies (HMs), such aso Harmonize the outcome measures;o Increase the availability of omics data;o Speed up of drug development, access

pathways and ‘bench-to-bedside’ processes.

− Will capture, integrate, analyze and harmonize anonymous patient data from high-quality multidisciplinary sources and apply Big Data techniques;

− Will unlock valuable knowledge across the spectrum of hematologic malignancies (blood cancers), such as Multiple Myeloma (MM), Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma (NHL), Myelodysplastic Syndromes (MDS) and pediatric HMs;

1.3 Our reason for being − Unmet major needs for patients with

Hematologic Malignancies that can be addressed through analysis of Big Data and working with multiple stakeholders;

− Registration of novel drug compounds is increasingly hard, costly and time consuming; especially for compounds targeting small patient populations;

− Promising new treatments are delayed or not developed.

1.4 Our mission

− Provide better therapy access and improved care for patients with various hematologic malignancies by empowering clinicians, patients and policy stakeholders.

Communication is key for our success

PAGE 23

1.5 Our vision − We believe that by better understanding of the

evolution of diseases and data we will facilitate the right treatment to the right patient at the right time;

− We trust that by making use of today’s Big Data technologies in healthcare we can help accelerate the development of and access to new therapies and personalized treatment approaches.

− Prove the value of innovative therapies for HMs.

1.6 What we offerThe aims and outputs of the HARMONY Alliance in five years are to:

− Set up a data-sharing platform in HMs to enable more rapid definition of promising treatment strategies and to predict events likely to be associated with such strategies. HARMONY will initially focus on clinical and omics data, however in the future it is to be envisioned that additional data from patients, from health economics initiatives, from payers and other sources will be included as well;

− Develop and support a community of European HMs stakeholders;

− Share new insights and information on HMs; − Develop a framework for legal, ethical and

governance issues in HMs.

1.7 Work Package 7 (WP7)WP7 will function as the HARMONY Communications Hub, receiving input from the Work Packages internally to consistently communicate and disseminate externally, to amplify impact. The graphic below shows a flow chart on how to safeguard the flow of valuable content. See figure 2.

2. OVERALL COMMUNICATION STRATEGY

2.1 Harmony in HematologyThe HARMONY Alliance will maximize the impact of our work by optimizing the flow and exchange of knowledge, information and guidance to both internal and external target audiences.

− Internal communication will inspire, inform, connect, engage, align, and nurture collaboration;

− External communication will raise awareness, build a community, inform, engage, and nurture relations.

2.2 IdentityThe HARMONY Alliance in random keywords to capture tone-of-voice and image:

− Specialized| Focused; − High Quality | Knowledge; − Human | Personal | Patient friendly; − Health | Care; − Science | Industry (both from public and

private perspectives); − Bringing together | Connect | Align.

2.3 NamingTo safeguard clarity and consistency in our external and internal communications and all other dissemination related activities the following can be listed with regard to naming of HARMONY as a whole: We will speak of:

− HARMONY Alliance | later in text to be referred as HARMONY;

− HARMONY is the acronym for Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in Hematology;

− The HARMONY Alliance is a European Network of Excellence for Big Data in Hematology;

− The HARMONY is public private partnership, consisting of 51 partners from 11 countries;

− HARMONY Partners; − HARMONY Associated Members; − HARMONY has 8 Work Packages | some of the

Work Packages have Working Groups; − HARMONY has “Bench to Bedside Projects”.

PAGE 24

3. INTERNAL COMMUNICATIONS

3.1 Focus − Promote cooperation and engagement

between the large number of partners.

3.2 Internal target audiences − All contact persons and related colleagues of

the HARMONY Alliance Partners (Public and/or Private Organisations officially listed in the Grant Agreement; as well as organisation who will be officially appointed as Alliance Partner in the future);

− All contact persons of the HARMONY Alliance Associate Members (Public and/or Private Organisations who will be officially appointed as Associate Members in the future);

− Teams of Bench-to-Bedside Projects (Public and Private Organisations who are officially appointed in Project Teams);

− All contact persons of Governing bodies.

3.3 Internal communications objectives − Develop a multilateral communication

platform - WP7 provides easy-to-use ‘channels’ - which will result in clear, informative internal communications. WP1 is mainly responsible for internal communications;

− Ensure efficient vertical downward and upward communication flows, horizontal or lateral communication and diagonal communication within the HARMONY Alliance;

− Ensure re-evaluation mechanisms of the communication strategy.

3.4 Internal communications channels − Intranet; Newsletter; Newsflashes; Official

Alliance meetings; Position/white paper; email and other written internal communications; Ad-hoc discussions, face-to-face team meetings, Skype sessions, teleconferences and video conferences.

3.5 Internal databaseContact lists are available and managed by the Project Management Office.

3.6 Internal communications content flow − The core team of WP7 consists of EHA,

Novartis, Takeda, a WP1 representative and a Program Management Office representative;

− The core team of WP7 will connect and engage with the contact person of each Partner and Associated Member for external communication purposes;

− The Communication and Dissemination Board will provide input and will function as a soundboard for the core team.

4. EXTERNAL COMMUNICATIONS

4.1 Focus − Raise awareness, communicate message, and

disseminate outputs to external stakeholder audiences.

4.2 External Stakeholder GroupsKey individuals working at:

− Stakeholder group 1: Patient Organizations; − Stakeholder group 2: Hematologists and

Clinicians; − Stakeholder group 3: Medicine Authorities

(EU/EMA and national level; − Stakeholder group 4: HTA bodies; − Stakeholder group 5: Payers; − Stakeholder group 6: Pharmaceutical Industry

(EFPIA); − Stakeholder group 7: Policy makers and

Funding Organization (Including IMI and the European Commission);

− Stakeholder group 8: Information and Communications Technology Companies;

− Stakeholder group 9: Relevant other European and international Alliances;

− Stakeholder group 10: Other, such as media.

PAGE 25

4.3 Objectives external communications − Identify the right stakeholder contacts; − Establish early engagement to obtain new

findings and insight, e.g. on Big Data analysis; − Build the HARMONY Community; − Maintain fruitful relationships.

4.4 External communications channels − Website, social media, online magazine

(Harmony in Hematology), presentations, press-releases, posters, journal publications, videos, position/white papers, reports, articles & additional publications, training/dissemination events, sessions and booth presentations at European and International Conferences;

− In addition: Channels of Partners, Associated Members and IMI/EU; Personal media contacts; ANP press agency.

4.5 External communications content flow − The core team of WP7 consists of EHA,

Novartis, Takeda, WP1 representative and a PMO representative;

− The core team of WP7 will connect and engage with primary stakeholders;

− The Communication and Dissemination Board will provide input and will function as a soundboard for the core team.

5. GOOD COMMUNICATIONSThe HARMONY Alliance is an ambitious Network of Excellence and can be considered unique from various perspectives:

− Content: HARMONY will address the most urgent unmet needs of PATIENTS affected by HM in terms of diagnosis, therapy, and patient management;

− Approach: HARMONY will develop a HM-specific Big Data platform to enable rapid definition of promising treatment strategies;

− Funding: With funding of 40 million euros, HARMONY is the largest IMI project.

Key people and audiences around us are awaiting anxiously to view progress and of the HARMONY projects and activities the coming 5 years. Good communications are essential, which means building meaning building strong relationships leading to a thriving HARMONY community. The team of WP1 will focus on the internal communications guiding the deliverables which were agreed upon. The team WP7 will focus on communicating and disseminating the content of all WPs to external audiences. In the end HARMONY WP teams and Committees work for the same common goal: Enabling Better and Faster Treatment for Patients with Hematologic Malignancies.

PAGE 26

Figure 1.

Figure 2.

WP1

WP2

WP3

WP4

WP5

WP6

WP7

WP8

Diss

emin

atio

n

Com

mun

icat

ion

Boar

d

IMI

All o

utpu

t: Se

ts o

f sta

ndar

d ou

tcom

es; D

ata

colle

ctio

n, s

tora

ge a

nd

man

agem

ent s

tand

ards

; Reg

ualto

ry/P

olic

y; A

cces

s ev

iden

ce a

nd

clin

ical

val

ue fr

amew

ork.

Deliverab

les

O

nlin

e co

mm

unic

atio

ns

Pres

enta

tions

Pr

ess

rele

ases

Pu

blic

atio

ns

Trai

ning

/dis

sem

inat

ion

even

ts

Inte

rnat

iona

l Con

fere

nces

WP7 Hub

Project Coordination

Selection External Communications Dissemination

WGL1

WGL2

WGL3

WGL4

WGL5

WGL6

WGL7

WGL8

HARMONYAlliance|StreamliningCommunicationsandDissemination FlowchartforContentDevelopment

Selection Internal Communications

European Commission

Worl Health Organization

Big Data Initiatives

Other

Associated Members Internal Stakeholders

External Stakeholders Health/Hematology Sector

HARMONYAlliance|Ourcommunity

General Public

Committees and Advisory Boards Internal Stakeholders

Partners Internal Stakeholders

PAGE 27

Agencia Española del Medicamento y Productos Sanitarios (AEMPS) • Alma Mater Studiorum -

Università di Bologna (UNIBO) • AMGEN • Assistance Publique - Hôpitaux de Paris (AP-HP) • Barts

Health NHS Trust (BHT) • BAYER • Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)

• CELGENE • ELN Foundation (ELN) • Erasmus Universiteit Medisch Centrum Rotterdam (EMC) •

European Alliance for Personalised Medicine (EAPM) • European Hematology Association (EHA)

• European Organisation for Research and Treatment of Cancer (EORTC) • European Research

Initiative on CLL e.v. (ERIC) • European Society for Blood and Marrow Transplantation (EBMT)

• Flanders Institute of Biotechnology (VIB) • Fondazione Italiana per lo studio delle sindromi

mielodisplastiche onlus (FISMonlus) • Fundacio privada Institut D’investigacio Oncologica de Vall-

Hebron (VHIO) • Fundación para la Investigación del Hospital Universitario La Fe de la Comunidad

Valenciana (HULAFE) • Genome Research Limited (GRL-SANGER) • German Society of Pediatric

Oncology Hematology GmbH gemeinnützig (GPOH) • GMV Soluciones Globales Internet S.A.U.

(GMV) • Goethe University Frankfurt (GUF) • Group for Research on Adult Acute Lymphoblastic

Leukemia (GRAALL) • Groupe Francophone des Myélodysplasies (GFM) • Heinrich-Heine-

Universitaet - Duesseldorf (UDUS) • Fundación Instituto de Estudios de Ciencias de la Salud de

Castilla y León - IBSAL (IECSCYL-IBSAL) • Jose Carreras Leukaemia Research Institute (IJC) • JPNV-

JANSSEN • LeukaNET (LeNET) • Ludwig-Maximilians-Universitaet - Muenchen (LMU-Muenchen)

• Masaryk University (MU) • MediSapiens Ltd (MS) • Medizinische Universitaet - Wien (MUW) •

MENARINI • MLL Munich Leukemia Laboratory GmbH (MLL) • National Institute for Health and Care

Excellence (NICE) • NOVARTIS • Ospedale Pediatrico Bambino Gesù (OPBG) • Synapse Research

Management Partners (SYNAPSE) • TAKEDA • The Chancellor, Masters and Scholars of the

University of Cambridge (UCAM) • The Lymphoma Scientific Association (LYSA) • Università degli

Studi di Torino (UNITO) • Universitaet Ulm (UULM) • University of Helsinki (UH) • University of

Navarra (UNAV) • University of Newcastle upon Tyne (UNEW) • University of Rome ‘Tor Vergata’

(URTV) • University of York (UoY) • VU University Medical Center (VUmc)

Alliance Partners 2017

Annex 5

PAGE 28

HARMONY Communications OfficeEuropean Hematology Associations (EHA), The Hague, The Netherlands+31 70 302 0099communications@harmony-alliance.eu

www.harmony-alliance.eu @harmonyNetEU

About the HARMONY Alliance: Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in Hematology

The HARMONY Alliance is a European Network of Excellence for Big Data in Hematology, consisting of 51 partners. Our goal is unlocking valuable knowledge on hematologic malignancies (HMs). The HARMONY Alliance is funded through the Innovative Medicines Initiative (IMI), Europe’s largest public-private initiative aiming to speed up the development of better and safer medicines for patients. HARMONY has received funding from IMI 2 Joint Undertaking and is listed under grant agreement No. 116026. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Program and the European Federation of Pharmaceutical Industries and Associations (EFPIA). IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.

Contact